Literature DB >> 21356388

Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1/FGFR3 signaling and increased invasion.

Maria L Henriksson1, Sofia Edin, Anna M Dahlin, Per-Arne Oldenborg, Åke Öberg, Bethany Van Guelpen, Jörgen Rutegård, Roger Stenling, Richard Palmqvist.   

Abstract

Cancer-associated fibroblasts expressing fibroblast activation protein (FAP) have been implicated in the invasive behavior of colorectal cancer. In this study, we use FAP expression as a marker of fibroblast activation and analyze the effect of activated fibroblasts on colorectal cancer migration and invasion in experimental cell studies. We also investigated the expression pattern of FAP in cancer-associated fibroblasts during transformation from benign to malignant colorectal tumors. In immunohistochemical analyses, FAP was expressed in fibroblasts in all colorectal cancer samples examined, whereas all normal colon, hyperplastic polyps, or adenoma samples were negative. In in vitro studies, conditioned medium from colon cancer cells, but not adenoma cells, activated fibroblasts by inducing FAP expression. These activated fibroblasts increased the migration and invasion of colon cancer cells in Boyden chamber experiments and in a three-dimensional cell culture model. We identify fibroblast growth factor 1/fibroblast growth factor receptor 3 (FGF1/FGFR-3) signaling as mediators leading to the increased migration and invasion. Activated fibroblasts increase their expression of FGF1, and by adding a fibroblast growth factor receptor inhibitor, as well as an FGF1-neutralizing antibody, we reduced the migration of colon cancer cells. Our findings provide evidence of a possible molecular mechanism involved in the cross talk between cancer cells and fibroblasts leading to cancer cell invasion.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21356388      PMCID: PMC3070577          DOI: 10.1016/j.ajpath.2010.12.008

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers.

Authors:  P Garin-Chesa; L J Old; W J Rettig
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 2.  Tumor stroma.

Authors:  R Seljelid; S Jozefowski; B Sveinbjörnsson
Journal:  Anticancer Res       Date:  1999 Nov-Dec       Impact factor: 2.480

3.  Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration.

Authors:  G Sonvilla; S Allerstorfer; C Heinzle; S Stättner; J Karner; M Klimpfinger; F Wrba; H Fischer; C Gauglhofer; S Spiegl-Kreinecker; B Grasl-Kraupp; K Holzmann; M Grusch; W Berger; B Marian
Journal:  Br J Cancer       Date:  2010-03-16       Impact factor: 7.640

4.  The role of myofibroblasts at the tumor border of invasive colorectal adenocarcinomas.

Authors:  H Nakayama; H Enzan; E Miyazaki; K Naruse; H Kiyoku; M Hiroi
Journal:  Jpn J Clin Oncol       Date:  1998-10       Impact factor: 3.019

5.  Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer.

Authors:  Satoshi Iwasa; Xin Jin; Kyoko Okada; Masako Mitsumata; Akishi Ooi
Journal:  Cancer Lett       Date:  2003-09-10       Impact factor: 8.679

6.  Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers.

Authors:  M J Scanlan; B K Raj; B Calvo; P Garin-Chesa; M P Sanz-Moncasi; J H Healey; L J Old; W J Rettig
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

7.  Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells.

Authors:  W J Rettig; P Garin-Chesa; H R Beresford; H F Oettgen; M R Melamed; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

8.  Fibroblast activation protein: purification, epitope mapping and induction by growth factors.

Authors:  W J Rettig; S L Su; S R Fortunato; M J Scanlan; B K Raj; P Garin-Chesa; J H Healey; L J Old
Journal:  Int J Cancer       Date:  1994-08-01       Impact factor: 7.396

9.  Fibroblast growth factors modulate intestinal epithelial cell growth and migration.

Authors:  A U Dignass; S Tsunekawa; D K Podolsky
Journal:  Gastroenterology       Date:  1994-05       Impact factor: 22.682

Review 10.  Stromal cell involvement in cancer.

Authors:  Kasper Almholt; Morten Johnsen
Journal:  Recent Results Cancer Res       Date:  2003
View more
  48 in total

1.  Fibrogenic Lung Injury Induces Non-Cell-Autonomous Fibroblast Invasion.

Authors:  Neil Ahluwalia; Paula E Grasberger; Brian M Mugo; Carol Feghali-Bostwick; Annie Pardo; Moisés Selman; David Lagares; Andrew M Tager
Journal:  Am J Respir Cell Mol Biol       Date:  2016-06       Impact factor: 6.914

Review 2.  Genomic diversity of colorectal cancer: Changing landscape and emerging targets.

Authors:  Daniel H Ahn; Kristen K Ciombor; Sameh Mikhail; Tanios Bekaii-Saab
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 3.  miRNAs derived from cancer-associated fibroblasts in colorectal cancer.

Authors:  Amir Savardashtaki; Zahra Shabaninejad; Ahmad Movahedpour; Roxana Sahebnasagh; Hamed Mirzaei; Michael R Hamblin
Journal:  Epigenomics       Date:  2019-11-08       Impact factor: 4.778

4.  Proteomic analysis of primary colon cancer-associated fibroblasts using the SELDI-ProteinChip platform.

Authors:  Zhan-Huai Wang; Ke-Feng Ding; Jie-Kai Yu; Xiao-Hui Zhai; Shu-Qin Ruan; Shan-Wei Wang; Yong-Liang Zhu; Shu Zheng; Su-Zhan Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2012-03       Impact factor: 3.066

5.  Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer.

Authors:  Choong-Kun Lee; Myung Eun Lee; Won Suk Lee; Jeong Min Kim; Kyu Hyun Park; Tae Soo Kim; Kang Young Lee; Joong Bae Ahn; Hyun Cheol Chung; Sun Young Rha
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

Review 6.  Molecular mechanism underlying the tumor-promoting functions of carcinoma-associated fibroblasts.

Authors:  Yali Han; Yanwen Zhang; Tanghong Jia; Yuping Sun
Journal:  Tumour Biol       Date:  2015-02-15

Review 7.  Cancer-associated fibroblasts: how do they contribute to metastasis?

Authors:  Mei Qi Kwa; Kate M Herum; Cord Brakebusch
Journal:  Clin Exp Metastasis       Date:  2019-03-07       Impact factor: 5.150

8.  Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells.

Authors:  Julia Schulte; Michaela Weidig; Philipp Balzer; Petra Richter; Marcus Franz; Kerstin Junker; Mieczyslaw Gajda; Karlheinz Friedrich; Heiko Wunderlich; Arne Östman; Iver Petersen; Alexander Berndt
Journal:  Histochem Cell Biol       Date:  2012-07-22       Impact factor: 4.304

Review 9.  The gastrointestinal tumor microenvironment.

Authors:  Michael Quante; Julia Varga; Timothy C Wang; Florian R Greten
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

10.  Sunitinib mesylate inhibits proliferation of human colonic stromal fibroblasts in vitro and in vivo.

Authors:  Zhan-huai Wang; Qiong Li; Shu-qin Ruan; Qian Xiao; Yue Liu; Ye-ting Hu; Li-feng Hu; Hai-yan Chen; Shu Zheng; Su-zhan Zhang; Ke-feng Ding
Journal:  J Zhejiang Univ Sci B       Date:  2014-08       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.